MiR-652-3p is upregulated in non-small cell lung cancer and promotes proliferation and metastasis by directly targeting Lgl1

Our previous study found that miR-652-3p is markedly upregulated in the serum of patients with NSCLC and suggesting that miR-652-3p is a potential biomarker for the early diagnosis of NSCLC. In this study, we detected the expression of miR-652-3p in NSCLC tumor tissues and cell lines and investigate...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Yang, Wenhui, Zhou, Chengcheng, Luo, Mei, Shi, Xuejiao, Li, Yuan, Sun, Zengmiao, Zhou, Fang, Chen, Zhaoli, He, Jie
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2016
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4941345/
https://ncbi.nlm.nih.gov/pubmed/26934648
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7697
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi